Investigational Site Number 056002

Antwerp B-2020

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Hematopoietic Neoplasm

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed